USAN Council Adopts TAM Nonproprietary Name
Summary
The USAN Council, operating in cooperation with the FDA, has adopted the nonproprietary name 'TAM' for a substance. The adopted name has been filed with the FDA as a public notice. This naming action establishes the official United States Adopted Name for the substance, which will serve as its standard nonproprietary designation in pharmaceutical and medical contexts.
What changed
The USAN Council has officially adopted the nonproprietary name 'TAM' for a substance, with the adoption filed and documented through the FDA's regulatory docket system. This is a routine nomenclature action establishing the standardized US Adopted Name.
Affected parties in the pharmaceutical and healthcare sectors should note the newly adopted name for compliance with labeling, prescribing, and regulatory documentation requirements where nonproprietary names are specified.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.